Mecapegfilgrastim (Hengrui)

硫培非格司亭（恒瑞）

Report date: 2022/10/27 11:15:22

Base Information

Drug NameMecapegfilgrastim (Hengrui)
Drug Alias NamePegylated rhG-CSF聚乙二醇重组人粒细胞刺激因子注射液硫培非格司亭注射液Mecapegfilgrastim InjectionPegfilgrastim biosimilar (Hengrui) +[7] 
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionColony stimulating factor 3 receptor agonists
TargetsColony stimulating factor 3 receptor
Therapy Area/IndicationsChemotherapy-induced myelosuppressionFebrile NeutropeniaNeutropenia +[7] 
Global Approved IndicationsNeutropenia
Approved Indications in ChinaNeutropenia
Original Approved Country/TerritoryMainland China
Original Approved Date2018/05/08
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesJiangsu Hengrui Medicine Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAffiliated Hospital Of Nantong UniversityJiangsu Hengrui Medicine Co Ltd
Inactive CompaniesN/A
Active IndicationsChemotherapy-induced myelosuppressionNeutropeniaThoracic Neoplasms
Inactive IndicationsFebrile NeutropeniaCarcinoma, Non-Small-Cell LungBreast Neoplasms +[4] 

Other Information

ATC CodeL03AA13
Related LinksN/A